Black Rock Inc. Aditxt, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.13 - $0.46 $4,170 - $14,758	-32,084 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.34 - $0.58 $535 - $913	-1,575 Reduced 4.68%	32,084 $15,000
Q4 2021 Feb 10, 2022	BUY	$0.54 - $2.51 $472 - $2,196	875 Added 2.67%	33,659 $18,000
Q3 2021 Nov 09, 2021	SELL	$1.54 - $3.04 $1,078 - $2,128	-700 Reduced 2.09%	32,784 $55,000
Q2 2021 Aug 11, 2021	BUY	$2.2 - $3.2 $73,664 - $107,148	33,484 New	33,484 $86,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $1.37M
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.